CompletedNot Applicable

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

United States668 participantsStarted 2017-11-02

Plain-language summary

GRACE is a randomized 3-arm trial to determine the comparative effectiveness of two remote cancer communication interventions: 1) a targeted generic print (TP) or 2) a tailored telephone-based counseling and navigation intervention (TCN). Post-award, the target sample size was revised to (n=642) with NIH permission.

Who can participate

Age range21 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Breast Cancer * Hispanic or non-Hispanic * Female * 21 years of age or older * English-speaking * Breast cancer history * breast cancer at the age of 50 or younger OR * triple-negative breast cancer OR * two or more primary breast cancers Ovarian Cancer * Hispanic or non-Hispanic * Female * 21 years of age or older * English-speaking * History of ovarian, fallopian, or peritoneal cancer diagnosed at any age Exclusion Criteria: Have had prior genetic counseling or testing for hereditary breast and/or ovarian cancer

What they're measuring

Medically Verified Cancer Genetic Risk Assessment Uptake at 6 Months

Timeframe: 6 months following the interventions for TP and TCN, and 6 months following the baseline survey for the UC arm.

Trial details

NCT IDNCT03326713

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-02

Results submitted2025-04-21

View on ClinicalTrials.gov More Breast Cancer trials